These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37691479)

  • 21. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
    Beliveau CM; McMahan VM; Arenander J; Angst MS; Kushel M; Torres A; Santos GM; Coffin PO
    Subst Abus; 2022; 43(1):179-186. PubMed ID: 33798030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of prescribing indicators related to opioid-related harm in patients with chronic pain in primary care-a modified e-Delphi study.
    Bansal N; Campbell SM; Lin CY; Ashcroft DM; Chen LC
    BMC Med; 2024 Jan; 22(1):5. PubMed ID: 38167142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive, Evidence-Based, Consensus Guidelines for Prescription of Opioids for Chronic Non-Cancer Pain from the American Society of Interventional Pain Physicians (ASIPP).
    Manchikanti L; Kaye AM; Knezevic NN; Giordano J; Applewhite MK; Bautista A; Soin A; Blank SK; Sanapati MR; Karri J; Christo PJ; Abd-Elsayed A; Kaye AD; Calodney A; Navani A; Gharibo CG; Harned M; Gupta M; Broachwala M; Sehgal N; Kaufman A; Wargo B; Solanki DR; Hsu ES; Limerick G; Dennis A; Swicegood JR; Slavin K; Snook L; Pasupuleti R; Kosanovic R; Justiz R; Barkin R; Atluri S; Shah S; Pampati V; Helm Ii S; Grami V; Myckowiak V; Galan V; Singh V; Manocha V; Hirsch JA
    Pain Physician; 2023 Dec; 26(7S):S7-S126. PubMed ID: 38117465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Pain and Opioid Use Disorder.
    Ganguly A; Michael M; Goschin S; Harris K; McFarland DC
    Oncology (Williston Park); 2022 Sep; 36(9):535-541. PubMed ID: 36107782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Opioids on Immune and Endocrine Function in Patients with Cancer Pain.
    Bradley A; Boland JW
    Curr Treat Options Oncol; 2023 Jul; 24(7):867-879. PubMed ID: 37145383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily opioid and stimulant co-use and nonfatal overdoses in the context of social disadvantage: Findings on marginalized populations.
    Jones AA; Schneider KE; Tobin KE; O'Sullivan D; Latkin CA
    J Subst Use Addict Treat; 2023 Aug; 151():208986. PubMed ID: 36822268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creating a Palliative Care Clinic for Patients with Cancer Pain and Substance Use Disorder.
    Kale SS; Tosto GD; Rush LJ; Kullgren J; Russell D; Fried M; Igboeli B; Teater J; Jones KF; Check DK; Merlin J; McAlearney AS
    J Pain Symptom Manage; 2024 Aug; 68(2):e138-e145. PubMed ID: 38670295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
    Thakrar AP; Uritsky TJ; Christopher C; Winston A; Ronning K; Sigueza AL; Caputo A; McFadden R; Olenik JM; Perrone J; Delgado MK; Lowenstein M; Compton P
    Addict Sci Clin Pract; 2023 Feb; 18(1):13. PubMed ID: 36829242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.
    Rosenblum A; Cruciani RA; Strain EC; Cleland CM; Joseph H; Magura S; Marsch LA; McNicholas LF; Savage SR; Sundaram A; Portenoy RK
    J Opioid Manag; 2012; 8(6):369-82. PubMed ID: 23264315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.
    McCormick Z; Chu SK; Chang-Chien GC; Joseph P
    Pain Med; 2013 Aug; 14(8):1187-91. PubMed ID: 23647815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute pain service reduces barriers to buprenorphine/naloxone initiation by using regional anesthesia techniques.
    Seol A; Chan J; Micham B; Ye Y; Mariano ER; Harrison TK; Hunter OO
    Reg Anesth Pain Med; 2023 Aug; 48(8):425-427. PubMed ID: 36792313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of problematic behaviours among individuals on long-term opioid therapy: protocol for a Delphi study.
    Merlin JS; Young SR; Azari S; Becker WC; Liebschutz JM; Pomeranz J; Roy P; Saini S; Starrels JL; Edelman EJ
    BMJ Open; 2016 May; 6(5):e011619. PubMed ID: 27154486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dancing with Deterrents: Understanding the Role of Abuse-Deterrent Opioid Formulations and Naloxone in Managing Cancer Pain.
    Mitchell MT
    Oncologist; 2019 Dec; 24(12):1505-1509. PubMed ID: 31152083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing Opioids, Including Misuse and Addiction, in Patients With Serious Illness in Ambulatory Palliative Care: A Qualitative Study.
    Merlin JS; Young SR; Arnold R; Bulls HW; Childers J; Gauthier L; Giannitrapani KF; Kavalieratos D; Schenker Y; Wilson JD; Liebschutz JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):507-513. PubMed ID: 31763926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine-Naloxone in the Setting of Kratom Withdrawal, Opioid Use Disorder, and Stage IV Lung Adenocarcinoma.
    Hong S; Zimmerman PE; Rao V; Markwalter DW
    J Palliat Med; 2023 May; 26(5):734-736. PubMed ID: 36580544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process.
    Goel A; Azargive S; Weissman JS; Shanthanna H; Hanlon JG; Samman B; Dominicis M; Ladha KS; Lamba W; Duggan S; Di Renna T; Peng P; Wong C; Sinha A; Eipe N; Martell D; Intrater H; MacDougall P; Kwofie K; St-Jean M; Rashiq S; Van Camp K; Flamer D; Satok-Wolman M; Clarke H
    Br J Anaesth; 2019 Aug; 123(2):e333-e342. PubMed ID: 31153631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain.
    Yennurajalingam S; Arthur J; Reddy S; Edwards T; Lu Z; Rozman de Moraes A; Wilson SM; Erdogan E; Joy MP; Ethridge SD; Kuriakose L; Malik JS; Najera JM; Rashid S; Qian Y; Kubiak MJ; Nguyen K; PharmD ; Wu J; Hui D; Bruera E
    JAMA Oncol; 2021 Mar; 7(3):404-411. PubMed ID: 33410866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid safety recommendations in adult palliative medicine: a North American Delphi expert consensus.
    Lau J; Mazzotta P; Whelan C; Abdelaal M; Clarke H; Furlan AD; Smith A; Husain A; Fainsinger R; Hui D; Sunderji N; Zimmermann C
    BMJ Support Palliat Care; 2022 Mar; 12(1):81-90. PubMed ID: 34389553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.